Holocene Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.2M | Sell |
3,053,340
-967,288
| -24% | -$16.2M | 0.12% | 165 |
|
|
2025
Q1 | $61.8M | Buy |
4,020,628
+851,215
| +27% | +$13.1M | 0.18% | 147 |
|
|
2024
Q4 | $69.9M | Buy |
3,169,413
+957,330
| +43% | +$21.1M | 0.22% | 130 |
|
|
2024
Q3 | $39.9M | Sell |
2,212,083
-2,374,189
| -52% | -$42.8M | 0.16% | 170 |
|
|
2024
Q2 | $74.5M | Sell |
4,586,272
-376,184
| -8% | -$6.11M | 0.31% | 97 |
|
|
2024
Q1 | $70M | Sell |
4,962,456
-295,739
| -6% | -$4.17M | 0.26% | 124 |
|
|
2023
Q4 | $54.9M | Buy |
5,258,195
+135,422
| +3% | +$1.41M | 0.21% | 141 |
|
|
2023
Q3 | $52.3M | Buy |
+5,122,773
| New | +$52.3M | 0.23% | 132 |
|